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Abstract: A national internet survey was conducted between March and April 2009 among 
27,302 US participants in the Harris Interactive Chronic Illness Panel. Respondents reported 
behaviors related to cost-related medication non-adherence (CRN) and the impacts of medication 
costs on other aspects of their daily lives. Among respondents aged 40–64 and looking for 
work, 66% reported CRN in 2008, and 41% did not fill a prescription due to cost pressures. 
More than half of respondents aged 40–64 and nearly two-thirds of those in this group who 
were looking for work or disabled reported other impacts of medication costs, such as cutting 
back on basic needs or increasing credit card debt. More than one-third of respondents aged 
65+ who were working or looking for work reported CRN. Regardless of age or employment 
status, roughly half of respondents reporting medication cost hardship said that these problems 
had become more frequent in 2008 than before the economic recession. These data show that 
many chronically ill patients, particularly those looking for work or disabled, reported greater 
medication cost problems since the economic crisis began. Given links between CRN and 
worse health, the financial downturn may have had significant health consequences for adults 
with chronic illness.
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Introduction
In 2008, the American economy entered one of the deepest recessions since World 
War II.1 According to the Bureau of Labor Statistics, unemployment rates were roughly 
constant at an average of 4.7% throughout 2007 but increased to 7.2% by the end of 
2008.2 Financial markets were hit hard, with the Dow experiencing a 32% decline 
between the beginning of 2008 and the year’s end.3 Home foreclosures increased 40% 
between 2007 and 2008, and personal bankruptcies increased by more than 31%, with an 
additional quarter of a million consumers filing in 2008 relative to the year before.4
For chronically ill patients, the financial upheaval was experienced in the context 
of an ongoing crisis in American healthcare with many Americans struggling to afford 
their prescription medications. Studies from the early to mid-2000s found that as many 
as one-third of older adults reported taking less medication than prescribed due to cost 
pressures.5–7 In addition to failing to fill prescriptions or taking less than prescribed to 
make their treatments last longer, some patients reported cutting back on basic needs 
in order to pay for their prescription drugs.8,9 The negative health implications of cost-
related non-adherence (CRN) – including rehospitalization, emergency room use, and 
cardiovascular events – have been well documented by studies using administrative 
data and large national surveys.10–14 Patients with chronic illnesses are particularly at 
risk for CRN and poor health outcomes as a result.15Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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The Medicare Modernization Act Prescription Drug 
Benefit (Part D) was designed to address escalating 
medication-cost problems among Medicare enrollees. In a 
study one year before the benefit took effect, Soumerai and 
colleagues found that 12.6% of elderly Medicare enrollees 
reported some CRN and that rates were as high as 29.4% 
among non-elderly disabled enrollees.5 Enrollees in poor 
health or who had multiple chronic conditions were at the 
highest risk for CRN. Using data from the years immediately 
following the implementation of Part D (2006–2007), 
researchers have reported moderate decreases in CRN and 
increased spending on prescription drugs.9,16 While these 
changes may translate into better health outcomes for some 
patients, those with more chronic illnesses have shown 
fewer benefits.9,16 The limited impact of Part D may reflect 
the large numbers of eligible patients who fail to enroll17,18 
as well as the sizable number of enrollees who reach the 
“doughnut hole” (19% of all Part D enrollees and as many as 
49% of patients taking medication for stroke or myocardial 
infarction19), leaving them uncovered for their prescription-
medication expenses. In an era in which home prices lost on 
average 30% of their value and the nation’s collective net 
worth decreased more than three trillion dollars,20 the ability 
of older adults to continue affording their medications with 
or without Part D covered should be reexamined.
While older adults have a higher prevalence of chronic 
illnesses and unique medication use needs, a review of the 
literature reported higher rates of CRN among younger 
patients in 11 out of 13 studies identified.15 Because most 
“working age” individuals are ineligible for the Part D 
benefit, the impact on this group of the recent economic crisis 
may have been particularly severe. As such, understanding 
the rates of CRN among adults under 65 years of age and 
comparing disparities between those rates and rates among 
individuals eligible for Part D represent important goals 
for research on ways to improve medication coverage and 
prevent costly health crises.
To examine how the economic downturn impacted cost-
related medication problems, we analyzed a nation survey of a   
diverse panel including more than 27,000 chronically ill older 
adults. We were particularly interested in understanding: 
1) recent prevalences of cost-related medication underuse 
and other financial hardships due to medication-cost 
pressures; 2) whether patients’ medication-cost problems 
worsened since the beginning of the economic recession 
relative to the year before; and 3) whether Part D coverage 
helped buffer those aged 65 and older from medication-cost 
hardships.
Methods
study population
Study participants were part of the Harris Interactive Chronic 
Illness Panel (CIP), which is a national, internet-based 
panel of adults with chronic diseases. CIP participants are 
recruited through a number of avenues including postal mail 
invitations, TV advertisements, telephone recruitment for 
under-represented populations, targeted email solicitations, 
and text banner placement on partners’ websites, eg, social 
media sites, news sites, search engine sites, and community 
portals. Panel recruitment and maintenance efforts are 
focused on maintaining a representative sample of the 
general population as well as identifying and reaching under-
represented and hard-to-reach groups.
In February and March of 2009, randomly selected 
members of the CIP were sent an e-mail invitation to 
participate in the survey. Panel members were eligible for 
participation if they were aged 40 and older, resided in the 
US, and reported one of six chronic diseases prevalent among 
US adults: hypertension, hyperlipidemia, diabetes, asthma, 
osteoporosis, and depression. The study was approved by the 
George Mason University Institutional Review Board.
Of the 51,774 CIP panel members who were US residents 
aged 40 or older and completed the chronic-disease screener, 
27,302 persons with chronic diseases (53%) completed the 
survey. CIP members who were successfully contacted were 
more likely to be aged 50 or older, male, white, college edu-
cated, and of higher income than unsuccessfully contacted 
members (all P , 0.0001).
Measures
Participants responded to a series of questions regarding 
strategies adults use to reduce medication use in order to 
minimize out-of-pocket costs, such as a delay in filling a 
prescription or stopping a prescription all together. Respondents 
also reported other financial impacts of prescription-medication 
expenditures, such as cutting-back on spending for basic 
necessities or increasing credit card debt. Items were adapted 
based on a review of measures in prior surveys conducted 
by the Medicare Current Beneficiary Survey, the AARP, the 
Kaiser Family Foundation, and other groups.7,21–30 The timing 
of each medication-cost impact was emphasized using the 
question stem: “In 2008, because of the cost of all of [your] 
prescription medications …” Each cost-reducing strategy was 
measured using a five-point scale ranging from “Yes, very 
often” to “No, never”. In subsequent questions, respondents 
who reported a given impact of medication-cost pressures were 
asked whether the problem was experienced “more frequently Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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in 2008 than in 2007”, “about the same in 2008 as in 2007”, or 
“less frequently in 2008 than in 2007”. In addition to reporting 
data on individual CRN behaviors, summary measures were 
created for any cost-related non-adherence and any other 
financial impact of medication costs.
Additional data about the sociodemographic characteristics 
of respondents was available from information they provided 
as enrollees in the CIP. These included respondents’ 
race/ethnicity (collected as white non-Hispanic, Hispanic, 
black non-Hispanic, and other race/ethnicity), educational 
attainment, and income. Household income was reported using 
11 categories ranging from ,US$15,000 per year to $250,000 
or more. Respondents reported their employment status in 
the following categories: employed full-time, employed part-
time, unemployed and looking for work, unemployed and 
not looking for work, disabled and unable to work, full time 
student, or full time homemaker. For the analyses presented 
here, participants were considered “unemployed and not 
looking for work” if they reported being a full-time student 
(and did not report being employed full- or part-time) or they 
reported being a full-time homemaker. For respondents aged 
65+, those not reporting that they were employed (full- or part-
time) or looking for work, were categorized as retired.
Analysis
All analyses were conducted using sampling weights that 
allowed estimates to be generalized to the US population of 
chronically ill adults over the age of 40. Cross-tabulations 
and chi-square tests were used to examine variation in 
respondents’ sociodemographic and clinical characteristics 
across age groups (40–64 versus 65+). The prevalence of each 
potential medication-cost problem in 2008 was examined. 
Finally, the proportion of respondents reporting that a given 
problem occurred more frequently in 2008 than in 2007 was 
examined. Prevalences of each problem were estimated for the 
overall sample and within age groups (40–64 versus 65+). The 
sample was then stratified by age and variations in medication-
cost problems were examined across employment categories. 
All proportions were adjusted for potential confounders 
using logistic regression models with post-test probability 
estimation. Specifically, logistic models were used to examine 
variation across groups in respondents’ adjusted probability of 
experiencing each medication-cost problem in 2008. A second 
series of models was then executed to examine variation 
across age and employment categories in the probability 
of experiencing medication-cost problems that were more 
frequent in 2008 than in 2007. For age-and sex-adjusted 
analyses, multivariable logistic regression models were used 
to generate predicted probabilities (using population means 
for the age and sex variables) and to test for statistically 
significant differences for each medication-related problem. 
We set “employed” as the reference group for pair-wise 
significance testing of employment groups for those younger 
than 65 years and “retired” as the employment reference 
group for those 65 or older. All analyses were conducted 
with Stata 11.0 (College Station, TX) and survey weights 
were used to make all results as representative as possible to 
the US population with chronic illnesses. Auxiliary analyses 
also controlled for race and Hispanic ethnicity, educational 
attainment, and number of chronic diseases. Because those 
models did not show meaningful differences compared to the 
more parsimonious age/sex-adjusted models, the results of 
the age/sex-adjusted models are presented here.
Results
sample description
Just over one-third (35%) of the overall sample of 27,302 
respondents was aged 65 or older; 93.2% was white non-
Hispanic, 2.3% was black non-Hispanic, 0.7% was Hispanic, 
and the remaining 3.8% reported “other” race/ethnicity. 
Despite the slightly higher contact rates among male CIP 
participants, just over one half of the analytic sample (53%) 
was female. Survey respondents included 13,606 individuals 
who were employed either full-time, part-time or self-
employed. An additional 838 respondents were out of work 
and looking for a job; 2,251 were either stay-at-home spouses, 
students, or other respondents who were unemployed but not 
looking for work; 10,348 were retired; and 259 reported that 
they were disabled and unable to work (Table 1). Respondents 
aged 40–64 were more likely to be employed and have fewer 
chronic conditions, while those age 65 or older were more 
likely to be retired and report less income.
The majority of respondents in each employment group 
were white, and the proportion that was female ranged from 
48% among employed respondents to 78% among those 
who were unemployed but not looking for work. Annual 
household incomes varied around the 2007 national median 
of $50,000,31 with 32% of employed respondents reporting 
incomes lower than $50,000, and 83% of those who were 
disabled and unable to work reporting incomes below that 
level. The proportion of respondents reporting fair or poor 
health status ranged from 24% among employed individuals 
to 71% among those reporting that they were disabled and 
unable to work. Participants who reported that they were 
unemployed and looking for a job were, on average, 57 years 
of age, had no college degree (70%), were female (56%), Patient Preference and Adherence 2011:5
Table 1 sample description
  Age
40–64 65+
n 27,302 17,787 9,515
employment status
  employed 13,606 64.4 22.3
  Unemployeda 838 4.1 4.1
  not looking 2,251 12.4 n/a
  retired  10,348 17.3 76.5
  Disabled and unable to work 259 1.8 n/a
Female 14,572 53.7 58.1
race
  White 25,437 88.3 96.0
  Black  616 6.1 2.0
  hispanic 202 2.4 1.0
  Other 1,047 3.2 1.2
no college degree 15,572 65.0 71.9
Annual income ,$50,000 13,067 42.6 57.7
Fair/poor health 9,427 34.2 26.8
number of chronic conditions
 1 7,298 34.8 24.2
  2–3 15,746 53.5 64.0
 4 + 4,258 11.7 11.8
Notes: Percentages within age groups were calculated using sampling weights to 
estimate proportions within the Us non-institutionalized population aged 40 and 
older. All differences between age groups were statistically significant (P , 0.001). 
aUnemployed and looking for work.
Table 2 Adjusted* percentage of respondents reporting medication-cost problems in 2008 and reporting an increased frequency 
of cost problems in 2008 compared to 2007
  All ages 
(N = 27,302)
40–64 
(N = 17,787)
65+  
(9,515)
2008 Increase 2008 Increase 2008 Increase
Any cost-related non-adherence 44.2% 21.4% 49.6% 24.8% 30.3% 12.6%
Delayed filling 34.3 16.5 39.8 19.6 20.0 8.5
split or took fewer pills  33.9 15.0 38.0 17.7 23.2 8.0
Did not fill a new Rx at all 24.0 10.4 28.5 12.5 12.5 4.8
stopped taking rx altogether  18.7 8.3 22.3 10.0 9.4 3.8
Any other financial hardships 51.2 27.0 54.9 30.1 41.5 19.1
spent less on discretionary activities  45.8 22.7 49.0 25.0 37.4 16.6
spent less on necessities 32.5 14.8 36.0 17.1 23.4 8.8
increased credit card debt 23.9 11.3 26.4 13.0 17.7 6.9
Borrowed from family or friends 12.6 5.3 15.9 6.7 4.1 1.7
Notes: cell entries represent column percentages. “increases” represent the proportion of all respondents reporting both crn in 2008 and that the problem had become 
more frequent than in 2007. estimates were calculated using sampling weights to approximate the proportion within the Us non-institutionalized population aged 40 and older. 
*Estimates were adjusted for age and sex. All differences between age groups were statistically significant (P , 0.001).
Abbreviations: crn, cost-related medication non-adherence; rx, prescription.
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had incomes ,$50,000 (69%), and a large proportion (41%) 
reported fair or poor health status.
cost-related non-adherence and 
medication financial hardships by age
Overall, 44% of respondents reported some form of CRN in 
2008, and 51% reported other financial hardships associated 
with their prescription-drug costs (Table 2). One-third (34%) 
of respondents reported that they delayed filling a prescription 
in 2008 because they could not afford it, and 34% reported 
they split or cut pills or took fewer than prescribed in order to 
make the prescription last longer. Almost one quarter (24%) 
reported that they did not fill a prescription at all due to cost 
pressures. Medication-cost problems were consistently more 
common among respondents less than 65 years of age (all 
P , 0.001).
For each medication-cost problem, only 2%–3% of 
respondents reported experiencing the problem less frequently 
in 2008 than in 2007. In contrast, roughly half of those 
reporting each problem stated that they experienced it more 
frequently in 2008 compared to 2007 with the remaining 
respondents reporting each problem about “the same” 
frequency in 2008 as 2007. For example, of the 34% of 
respondents who reported that they delayed refilling a 
prescription in 2008 because they could not afford it, nearly 
half of them (17% of all respondents) reported experiencing 
that problem more frequently in 2008 than in 2007. Overall, 
more than one in five respondents reported some form of 
CRN that was more frequent in 2008 than the year before. 
Among respondents aged 40–64, 25% reported CRN that 
had worsened in 2008.
cost-related non-adherence  
and medication-financial hardships  
across employment groups
Among respondents aged 40–64, medication-cost problems 
were prevalent across employment groups (Table 3). 
Nearly half (48%) of respondents within this age category 
who were employed and 66% of those who were looking 
for a job reported some form of CRN. Other medication Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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Table 3 Adjusted* percentage of respondents 40–64 years of age reporting medication-cost problems in 2008 and reporting an 
increased frequency of cost problems in 2008 compared to 2007 (N = 17,787)
Employed (ref) Looking for work Not looking Retired Disabled
2008 Increase 2008 Increase 2008 Increase 2008 Increase 2008 Increase
Any cost-related non-adherence 47.5% 22.3% 65.8%a 38.8%b 52.0%a 25.7%b 50.0% 26.0%b 57.2% 26.9%
Delayed filling 37.2 17.5 56.2a 29.8b 40.4 19.6 40.8a 20.4 48.8a 22.6
split or took fewer pills 36.4 15.7 49.7a 25.8b 39.8 18.1 36.8 18.8 41.7 19.0
Did not fill a new Rx at all 25.2 10.4 40.7a 21.1b 30.7a 12.0 30.2a 14.3 35.5a 10.4
stopped taking rx altogether 19.4 8.2 34.3a 19.6b 23.8a 10.2b 24.5a 10.6 27.0a 11.0
Any other financial impact 52.6 27.9 66.1a 36.3b 56.4a 29.9 58.6a 33.8 63.8a 34.4
spent less on discretionary activities 46.6 23.1 62.3a 31.6b 49.1 24.4 52.6a 28.5b 58.6a 26.9
spent less on necessities 32.5 14.8 47.6a 24.5b 38.3a 17.2 41.6a 20.6b 43.1a 19.8
increased credit card debt 26.0 12.5 28.9 14.5 25.6 13.6 27.0 13.2 27.1 13.8
Borrowed from family and friends 11.0 4.8 23.0a 9.3b 20.3a 6.9b 20.8a 8.3b 27.1a 7.9
Notes: cell entries represent column percentages. “increases” represent the proportion of all respondents reporting both crn in 2008 and that the problem had become 
more frequent than in 2007. estimates were calculated using sampling weights to approximate the proportion within the Us non-institutionalized population aged 40 and 
older. *estimates were adjusted for age and sex; aIndicates that the 2008 proportion in that employment group was statistically different (P , 0.05) than the 2008 proportion 
for employed respondents; bIndicates that the percentage of patients reporting an increase in CRN was statistically significantly different in that employment group relative 
to employed respondents. “employed” respondents reported that they were employed full-time, part-time, or self-employed. The group of respondents “not looking” for a 
job included respondents reporting that they were students or a stay-at-home “spouse, partner, husband, or wife”.
Abbreviations: crn, cost-related medication non-adherence; rx, prescription. 
financial hardships were also common. For example, 66% of 
those under 65 and looking for a job and 64% of those who 
were disabled reported they spent less on basic necessities 
or discretionary activities, increased their credit card 
debt burden, or borrowed money in order to pay for their 
prescription medications. More than half of those looking for 
a job who reported CRN in 2008 said that at least one of those 
hardships had worsened compared to 2007. For example, 
50% of all employment seekers aged 40–64 reported that they 
split, cut, or took fewer pills in order to make a prescription 
last longer in 2008, and 26% did so more frequently in 2008 
than in 2007. Respondents who were looking for a job or 
disabled, seeking a job, or were retired were more likely than 
employed respondents to report medication-cost problems 
that had worsened since the beginning of the recession.
Overall rates of medication-cost problems were lower 
among respondents over the age of 65 (Table 4). However 
26% of older adults reported that they were either working or 
looking for a job, and a large proportion of these individuals 
reported medication-cost hardships. For example, more than 
one-third of respondents who were over 65 and working 
reported some form of cost-related non-adherence in 2008, 
and 27% of working older adults reported that they split, cut, 
or took fewer pills in 2008 in order to make a prescription 
last longer. Problems were consistently more frequent among 
older adults who were working or looking for employment 
compared to those who were retired. A large proportion 
of older adults, particularly those who were either still 
working or looking for a job, reported that their medication-
cost problems had worsened in 2008 compared to 2007 
(and almost none reported that these problems had become 
less frequent, data not shown). For example, nearly half of the 
23% of working older adults who reported that they delayed 
filling a prescription in 2008 because they could not afford it 
said that this had become more frequent than in 2007 before 
the financial crisis. Regardless of their employment status, 
a substantial number of older adults reported that in 2008 
they more frequently experienced other financial impacts of 
their medication costs, such as spending less on necessities or 
discretionary activities, and increasing their debt burden.
Auxiliary analysis: multiple chronic 
conditions and the “working poor”
As noted in Table 1, most survey respondents had more than 
one chronic condition, and those with multiple illnesses may 
experience increased problems, both due to the increased burden 
of financial pressures and possibly the increased importance 
of medication use given their health status. Compared to 
the percentage of respondents reporting CRN among those 
with only one chronic disease (38% reporting CRN), CRN 
reports increased systematically among those reporting two 
(40%), three (45%), or 4+ illnesses (59%). Thirty percent of 
participants with four or more chronic conditions reported CRN 
that had worsened in 2008 compared to the prior year (compared 
to 16% of respondents with one diagnosis). Among respondents 
40–64 years of age, 65% of those with four or more conditions 
reported CRN, with more than half of them reporting worsening 
problems in 2008 compared to the year before.
A total of 2,472 respondents reported household incomes 
,$35,000 per year despite being employed. Because of Patient Preference and Adherence 2011:5
Table 4 Adjusted* percentage of respondents 65+ years of age reporting medication-cost problems in 2008 and reporting an increased 
frequency of cost problems in 2008 compared to 2007 (N = 9,515)
Retired (ref) Employed Looking for work
2008 Increase 2008 Increase 2008 Increase
Any cost-related non-adherence 28.7% 11.4% 34.0%a 14.3%b 43.2% 17.9%
Delayed filling 18.1 7.3 23.2a 9.9b 35.6a 15.1
split or took fewer pills 22.0 7.3 26.5a 8.7 26.5 11.0
Did not fill a new Rx at all 11.3 4.2 13.4 5.3 26.7a 9.2
stopped taking rx altogether 8.7 3.2 9.8 4.3 17.7 5.7
Any other financial impact 39.9 17.5 45.3a 21.7b 59.3a 35.5b
spent less on discretionary activities 35.7 15.2 41.3a 18.8b 58.4a 27.1
spent less on necessities 22.0 7.6 25.6 10.4b 34.3 12.5
increased credit card debt 16.2 5.7 21.6a 9.1b 29.3 13.9
Borrowed from family and friends 3.7 1.4 3.7 1.4 12.3 11.0b
Notes: cell entries represent column percentages. “increases” represent the proportion of all respondents reporting both crn in 2008 and that the problem had become 
more frequent than in 2007. *estimates were calculated using sampling weights to approximate the proportion within the Us non-institutionalized population aged 40 and 
older. estimates were adjusted for age and sex; aIndicates that the 2008 proportion in that employment group was statistically different (P , 0.05) than the 2008 proportion 
for retired respondents; bIndicates that the percent of patients reporting an increase in CRN was statistically significantly different in that employment group relative to retired 
respondents. “employed” respondents reported that they were employed full-time, part-time, or self-employed. “retired” respondents included those who reported that 
they were unemployed but not looking for work, students, stay-at-home partners, or disabled and unable to work.
Abbreviations: crn, cost-related medication non-adherence; rx, prescription.
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their limited resources and their higher likelihood of being 
uninsured, these “working poor” respondents represent an 
important subgroup. Two-thirds of this subsample (66%) 
reported CRN in 2008, and 70% reported other financial 
pressures due to their medication costs. Among those aged 
40–64, 70% of lower-income employed respondents reported 
CRN. Nearly one-third of the overall group of lower-income 
employed respondents reported CRN problems that had 
worsened in 2008 relative to the prior year.
Discussion
The results of this study provide evidence of a substantial 
increase in medication-cost problems associated with the 
recent economic recession. Madden and colleagues found 
that 8.6% of elderly Medicare beneficiaries in 2006 reported 
some cost-related medication non-adherence, and 5% 
reported spending less that year on basic needs.9 Depending 
on their employment status, 11%–27% of those in the 
current study aged 65 or older said that they delayed filling 
a prescription in 2008 because they could not afford it, and 
4–5 times as many older adults in the current study reported 
cutting back on basic needs compared to respondents in the 
Madden study. These relatively high rates of medication-cost 
problems in the current study relative to Madden’s study 
may reflect the greater illness severity of the current sample 
based on their chronic illnesses and/or increases in financial 
pressures on older adults due to the financial crises – and 
despite the availability of Part D benefits.
Because of the high unemployment rates associated with 
the current economic downturn and the difficulty unemployed 
people have obtaining health insurance in the US, it may not 
be surprising that we found a high prevalence of medication-
cost problems among respondents who were unemployed and 
looking for work or who were disabled. Nevertheless, it is 
important to point out that rates of medication-cost problems 
were high even among respondents who were working. 
A 2007 Commonwealth Fund survey showed that 24% of 
respondents with employer-based private health insurance did 
not fill a prescription due to cost problems, and a more recent 
survey found that increasing numbers of middle-income 
Americans spent at least 10% of their income on out-of-
pocket healthcare costs and premiums.32,33 Unfortunately, 
unemployment rates continued to climb between the time of 
this survey and the end of 2010, and the findings are at least 
as salient today as they were three years ago. As the current 
recession recedes and employment rates improve, we may see 
relative improvements in CRN. However, without significant 
health insurance reform, current trends toward less generous 
benefit packages could mean that negative impacts from 
out-of-pocket medication costs may remain common despite 
decreases in the unemployment rate.
As in many prior studies,15 these data suggest that rates of 
CRN are particularly high among chronically ill patients under 
the age of 65 who are ineligible for Part D coverage. Lower 
rates of CRN among older adults were reported in studies even 
before the Part D benefit was enacted, suggesting that factors 
such as greater overall financial assets and a higher priority 
placed on medication-taking also play roles in older patients’ 
willingness to pay for prescription medications in the context of 
out-of-pocket cost pressures. The associations between age and 
CRN suggested by the current study probably underestimate 
the actual age effects, since on average, older adults take more Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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medications and therefore face higher cost pressures. Political 
pressure to pass Part D as well as the ongoing debates about 
health care reform have largely de-emphasized these high 
rates of CRN among working-age adults or their potential 
consequences for rates of costly complications, morbidity, 
and preventable death. Given downward pressures on private 
insurance coverage, increasing rates of chronic disease, 
ongoing problems in the job market, and rising copayment 
rates, CRN among adults who are not eligible for Medicare 
should be continuously monitored and addressed.
Although this study used a large sample and provides some 
of the most recent information available about the impacts of 
prescription-drug costs on patients with chronic diseases, it 
has several important limitations. Respondents self-reported 
their perceptions about increases in medication-cost problems 
between 2007 and 2008. While this coincides directly with 
the onset of the financial crisis, other factors, such as illness 
progression or changes in insurance coverage unrelated to 
the recession, may have contributed to respondents’ greater 
cost-related medication problems over time. Medication cost 
pressures were reported taking the patient’s entire regimen 
into account, and as a result we cannot determine whether 
increases over time reflected more expensive prescriptions, 
a greater overall number of prescriptions, or costs within 
specific therapeutic classes. This study was conducted over 
the Internet. Only 53% of those screened completed the 
survey, and overwhelmingly, respondents were white. As a 
result, generalizability to the broader population should be 
made with caution. Nevertheless, estimates were relatively 
consistent with studies conducted using other survey 
methods, and sampling weights were used to correct for 
potential selection biases. To the extent that such biases exist, 
we would expect that individuals less comfortable using 
the Internet and those from racial/ethnic minority groups 
(particularly African-American and Hispanic patients) would 
tend to have less financial resources and therefore would be 
affected even more by the economic recession than what 
were suggested in this survey. Moreover, rates of medication 
underuse due to cost problems may be underestimated since 
patients who did not receive a prescription because they told 
their doctor they could not afford it were not identified in 
this study. Potential Medicare Part D beneficiaries who were 
aged less than 65 and reported that they were disabled and 
unable to work were not examined separately because data 
were not available on whether they met requirements for Part 
D or Medicaid coverage. If those potential respondents could 
have been identified, we assume that the relatively high rates 
of medication-cost problems would be even higher among 
the subset of disabled working-age Americans who do not 
have access to Part D or Medicaid coverage. Ideally, self-
reports of medication cost problems are linkable to other, 
objective measures of patients’ medication adherence, such 
as refill data from the Medicare Part D program. Of course, 
linking with Part D would only be possible for patients 
eligible for Part D coverage (eg, those .65 years of age or 
disabled). In the current study, linkage to refill/charge files 
was not possible. While this is a limitation with respect to 
understanding the specific prescription benefit characteristics 
and refilling consequences associated with cost-pressures, 
the broader population-based sampling frame of the current 
study provides a complement to research in which more 
comprehensive, linked datasets are possible.
Finally, as with any survey of medication-cost problems, 
results reflect respondents’ assessment of their medication-
taking behaviors, which could be subject to reporting and 
recall biases. Some patients may under-report medication 
under-use due to social desirability bias or may over-report 
the problem because they attribute recent declines in their 
health status to this behavior. Nearly 95% of this sample 
was white non-Hispanic, making it impossible to examine 
variation in cost-related adherence problems across racial 
and ethnic groups. Other studies suggest that racial/ethnic 
minorities may respond differently to economic pressures 
from their pharmacotherapy.34,35 Future studies should over-
sample these groups to ensure that important disparities are 
identified for African-American and Hispanic people with 
chronic diseases.
In this study, we found severe problems with CRN that 
substantially impacted all groups with chronic illnesses, 
including those who were .65 years of age and eligible for 
Medicare Part D. Rates of CRN were especially high among 
adults aged 40–64, those who were unemployed, those with 
multiple chronic conditions, and those with lower-incomes 
despite being employed. Policies and strategies are needed that 
can minimize the impact of economic stresses on adherence to 
medications that are the most important for preventing major 
medical complications or premature mortality.
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